tirzepatide niacinamide We are pleased to announce that we are expanding our Weight Management and Longevity offerings. Consider the / Injection in 4mL, a GIP and GLP-1 Receptor Agonist, for a variety Tirzepatide / Niacinamide – WP

MORPHEUS8 What it does: Combines microneedling with radiofrequency for deep collagen remodeling

Virtual consultation.

The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course

Transdermal delivery bypasses the digestive system, allowing for steady nutrient absorption while minimizing stomach discomfort